Stanley-Laman Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-4,973
Closed -$252K 250
2019
Q4
$252K Buy
+4,973
New +$257K 0.06% 253
2017
Q4
Sell
-7,799
Closed -$522K 274
2017
Q3
$522K Buy
7,799
+1,391
+22% +$98.3K 0.14% 173
2017
Q2
$499K Buy
6,408
+10
+0.2% +$755 0.14% 156
2017
Q1
$522K Sell
6,398
-1,832
-22% -$144K 0.14% 162
2016
Q4
$592K Buy
8,230
+4,057
+97% +$293K 0.18% 159
2016
Q3
$324K Buy
4,173
+50
+1% +$4.04K 0.13% 162
2016
Q2
$322K Sell
4,123
-877
-18% -$69.9K 0.13% 174
2016
Q1
$410K Sell
5,000
-9,208
-65% -$749K 0.08% 185
2015
Q4
$1.27M Buy
14,208
+9,208
+184% +$782K 0.22% 121
2015
Q3
$384K Hold
5,000
0.08% 223
2015
Q2
$418K Hold
5,000
0.08% 220
2015
Q1
$451K Hold
5,000
0.08% 220
2014
Q4
$404K Hold
5,000
0.08% 239
2014
Q3
$375K Hold
5,000
0.07% 227
2014
Q2
$343K Hold
5,000
0.06% 237
2014
Q1
$350K Buy
+5,000
New +$348K 0.06% 237

Other funds holding CAH

Stanley-Laman Group's CAH Position: Q1 2020 in Review

Stanley-Laman Group sold out of Cardinal Health (CAH) in Q1 2020, closing a stake of 4,973 shares — an estimated $252K sold.

Stanley-Laman Group first reported a position in CAH in Q1 2014 and held it in 16 quarters. The position peaked at $1.27M in Q4 2015. 721 funds tracked by Wall St. Rank hold CAH as of Q1 2020.

  • Stanley-Laman Group reported no remaining Cardinal Health position as of Q1 2020 after selling out during the quarter.
  • Stanley-Laman Group sold 4,973 Cardinal Health shares in Q1 2020, an estimated $252K.
  • Stanley-Laman Group first reported a position in Cardinal Health in Q1 2014 and held it in 16 quarters.
  • Stanley-Laman Group's Cardinal Health position peaked at $1.27M in Q4 2015.
  • 721 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2020.

Based on Stanley-Laman Group's 13F filing for Q1 2020, filed 12 May 2020.